全文获取类型
收费全文 | 19575篇 |
免费 | 1503篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 262篇 |
儿科学 | 619篇 |
妇产科学 | 447篇 |
基础医学 | 2830篇 |
口腔科学 | 314篇 |
临床医学 | 1861篇 |
内科学 | 3702篇 |
皮肤病学 | 299篇 |
神经病学 | 1978篇 |
特种医学 | 657篇 |
外科学 | 2620篇 |
综合类 | 614篇 |
现状与发展 | 1篇 |
一般理论 | 28篇 |
预防医学 | 1601篇 |
眼科学 | 543篇 |
药学 | 1346篇 |
中国医学 | 41篇 |
肿瘤学 | 1367篇 |
出版年
2023年 | 104篇 |
2022年 | 239篇 |
2021年 | 393篇 |
2020年 | 228篇 |
2019年 | 361篇 |
2018年 | 439篇 |
2017年 | 270篇 |
2016年 | 362篇 |
2015年 | 409篇 |
2014年 | 520篇 |
2013年 | 829篇 |
2012年 | 1164篇 |
2011年 | 1092篇 |
2010年 | 673篇 |
2009年 | 636篇 |
2008年 | 1034篇 |
2007年 | 1051篇 |
2006年 | 943篇 |
2005年 | 1034篇 |
2004年 | 1045篇 |
2003年 | 970篇 |
2002年 | 882篇 |
2001年 | 348篇 |
2000年 | 365篇 |
1999年 | 339篇 |
1998年 | 223篇 |
1997年 | 163篇 |
1996年 | 171篇 |
1995年 | 170篇 |
1994年 | 125篇 |
1993年 | 150篇 |
1992年 | 248篇 |
1991年 | 237篇 |
1990年 | 247篇 |
1989年 | 244篇 |
1988年 | 233篇 |
1987年 | 207篇 |
1986年 | 211篇 |
1985年 | 239篇 |
1984年 | 185篇 |
1983年 | 142篇 |
1982年 | 152篇 |
1981年 | 153篇 |
1980年 | 132篇 |
1979年 | 126篇 |
1977年 | 101篇 |
1976年 | 121篇 |
1975年 | 110篇 |
1974年 | 135篇 |
1973年 | 97篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
81.
82.
Roy Patterson C.R. Zeiss J.J. Pruzansky 《The Journal of allergy and clinical immunology》1982,70(1):19-23
Inhaled trimellitic anhydride (TMA) reacts with airway proteins to produce trimellityl (TM) proteins. The TM-proteins result in both systemic and local immune responses, of which various proteins present in the airway can be used for markers. Thus TM-human serum albumin (HSA), TM-IgG, and TM-IgA can be used as hapten-protein complexes for immunologic studies in sera of humans exposed to TMA by inhalation. Various immunologic assays have been established to measure antibodies against TM-proteins and have various purposes. With TM-HSA as a model antigen, total serum antibody may be measured by the ammonium sulfate technique of coprecipitation of TM-125I HSA. By solid-phase radioimmunoassays, IgE, IgG, IgA, and IgM antibodies can be measured. Lymphocyte reactivity can be measured by 3H thymidine uptake of TM-protein-stimulated lymphocytes. Biologic effects of IgE antibody can be measured by allergy skin tests and leukocyte histamine release with TM-proteins such as TM-HSA. The reaction of TMA with proteins results in alteration of those proteins that include changes in charge and physical conformation, the latter resulting in an apparent change in molecular size. These changes may relate to the observations that human antibody is not merely directed against the hapten in the hapten-human protein complex but also against new antigenic determinants formed by the TM-protein complex. Correlations have been made with certain human immunologic responses and lung disease after TMA inhalation, as follows: IgE antibody against TM-proteins correlates with TMA-induced rhinitis, conjunctivitis, and asthma; high levels of total antibody, IgG, and IgA antibody appear to correlate with the late respiratory systemic syndrome, probably a variant of hypersensitivity pneumonitis; workers exposed to TMA fumes (rather than TMA powder) have the highest levels of antibody, and this may correlate with occurrence of the hemorrhagic pneumonitis seen in this group of workers; patients with no symptoms or mild irritative symptoms have the lowest or no antibody levels. The immunopathogenetic relationships may be better understood with the further development of animal models of TMA lung disease now available. 相似文献
83.
84.
Neuropathological Diagnostic Criteria for Creutzfeldt-Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases) 总被引:12,自引:0,他引:12
Herbert Budka Adriano Aguzzi Paul Brown Jean-Marie Brucher Orso Bugiani Filippo Gullotta Matti Haltia Jean-Jacques Hauw James W. Ironside Kurt Jellinger Hans A. Kretzschmar Peter L. Lantos Carlo Masullo Wolfgang Schlote Jun Tateishi Roy O. Weller 《Brain pathology (Zurich, Switzerland)》1995,5(4):459-466
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human transmissible spongiform encephalopathies (prion diseases) are proposed for the following disease entities: CJD - sporadic, iatrogenic (recognised risk) or familial (same disease in 1st degree relative): spongiform encephalopathy in cerebral and/or cerebellar cortex and/or subcortical grey matter; or encephalopathy with prion protein (PrP) immuno-reactivity (plaque and/or diffuse synaptic and/or patchy/perivacuolar types). Gerstmann-Sträussler-Scheinker disease (GSS) (in family with dominantly inherited progressive ataxia and/or dementia): encephalo(myelo)pathy with multicentric PrP plaques. Familial fatal insomnia (FFI) (in member of a family with PRNP178 mutation): thalamic degeneration, variable spongiform change in cerebrum. Kuru (in the Fore population). Without PrP data, the crucial feature is the spongiform change accompanied by neuronal loss and gliosis. This spongiform change is characterised by diffuse or focally clustered small round or oval vacuoles in the neuropil of the deep cortical layers, cerebellar cortex or subcortical grey matter, which might become confluent. Spongiform change should not be confused with non-specific spon-giosis. This includes status spongiosus (“spongiform state”), comprising irregular cavities in gliotic neuropil following extensive neuronal loss (including also lesions of “burnt-out” CJD), “spongy” changes in brain oedema and metabolic encephalopathies, and artefacts such as superficial cortical, perineuronal, or perivascular vacuolation; focal changes indistinguishable from spongiform change may occur in some cases of Alzheimer's and diffuse Lewy body diseases. Very rare cases might not be diagnosed by these criteria. Then confirmation must be sought by additional techniques such as PrP immunoblotting, preparations for electron microscopic examination of scrapie associated fibrils (SAF), molecular biologic studies, or experimental transmission. 相似文献
85.
Rein Lepnurm Roy Dobson Allen Backman David Keegan 《Journal canadien de la médecine rurale》2007,12(4):217-230
INTRODUCTION: There are important differences in rural, regional and urban general practice environments. The purpose of this study was to articulate models that explain career satisfaction among general practitioners (GPs) in these practice environments. METHODS: Of 4958 eligible physicians across Canada, 2810 (56.7%) completed a 12- page survey between January and March 2004, from whom a total of 256 GPs in rural, regional and urban communities were selected. Response bias was checked and found to be negligible. We used hierarchical regression analysis to record cumulative R2, standardized beta and significance levels as each predictor was entered. We applied weighting factors to reflect the actual physician population in Canada. RESULTS: The models explained 88.5% of the variance in career satisfaction for GPs in small towns, 88.9% for GPs in regional communities and 86.3% for GPs in urban cities. The explanatory variables consisted of distress and coping, role in community activities, the quality of health care services and access to them, intrinsic and extrinsic rewards, workload and organizational structure. CONCLUSION: Career satisfaction for small-town doctors is associated with being able to cope with stress in handling a wide variety of clinical conditions, largely on their own, but with effective collaboration from physicians in larger centres. Rural GPs also enjoy academic responsibilities. Satisfaction for GPs in regional communities also depends on coping with stress and the ability to maintain an efficiently operating set of secondary- level health services in their community. Satisfaction for urban GPs is associated with collegiality, which dampens stress, and access to a full range of health services, including community, hospital, mental health and rehabilitation services. Career satisfaction for all GPs is associated with equity, manageable workloads and effective practice management; however, all of these professional issues contribute, in small increments, to satisfaction. 相似文献
86.
87.
88.
Stanton WR Saleheen HN O'Riordan D Roy CR 《International journal of behavioral medicine》2003,10(4):285-298
Sun exposure in childhood is 1 of the risk factors for developing skin cancer, yet little is known about levels of exposure
at this age. This is particularly important in countries with high levels of ultraviolet radiation (UVR) such as Australia.
Among 49 children 3 to 5 years of age attending child care centers, UVR exposure was studied under 4 conditions in a repeated
measures design; sunny days, cloudy days, teacher’s instruction to stay in the shade, and a health professionals instruction
to apply sunscreen. Three different data collection methods were employed: (a) completion of questionnaire or diary by parents
and researcher, (b) polysulphone dosimeter readings, and (c) observational audits (video recording).
Results of this study indicated that more than half the children had been sunburnt (pink or red) and more than a third had
experienced painful sunburn (sore or tender) in the last summer. Most wore short sleeve shirts, short skirts or shorts and
cap, that do not provide optimal levels of skin protection. However, sunscreen was applied to all exposed parts before the
children went out to the playground. Over the period of 1 hr (9–10 a.m.) the average amount of time children spent in full
sun was 22 min. On sunny days there was more variation across children in the amount of sun exposure received. While the potential
amount of UVR exposure for young children during the hour they were outside on a sunny day was 1.45 MED (Minimum Erythemal
Dose), they received on average 0.35 MED, which is an insufficient amount to result in an erythemal response on fair skin
even without the use of sunscreen. 相似文献
89.
90.